Click for best price
Emerging Cancer Diagnostics Market Size, Share 2022
Cancer diagnosis frequently requires imaging studies that in many cases use small amounts of radiation.
This report contains market size and forecasts of Emerging Cancer Diagnostics in Global, including the following market information:
Global Emerging Cancer Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Emerging Cancer Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Men Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Emerging Cancer Diagnostics include Abbott Laboratories, Danaher, Agilent Technologies, AstraZeneca, BD, Biocept, Illumina, Luminex and NeoGenomics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Emerging Cancer Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Emerging Cancer Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Emerging Cancer Diagnostics Market Segment Percentages, by Type, 2021 (%)
Men
Women
Global Emerging Cancer Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Emerging Cancer Diagnostics Market Segment Percentages, by Application, 2021 (%)
Blood Cancer
Prostate Cancer
Breast Cancer
Lung Cancer
Others
Global Emerging Cancer Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Emerging Cancer Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Emerging Cancer Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Emerging Cancer Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Danaher
Agilent Technologies
AstraZeneca
BD
Biocept
Illumina
Luminex
NeoGenomics
QIAGEN
Thermo Fisher Scientific
| Report Attributes |
Report Details |
| Report Title |
Emerging Cancer Diagnostics Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
61 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Emerging Cancer Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Emerging Cancer Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Emerging Cancer Diagnostics Overall Market Size
2.1 Global Emerging Cancer Diagnostics Market Size: 2021 VS 2028
2.2 Global Emerging Cancer Diagnostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Emerging Cancer Diagnostics Players in Global Market
3.2 Top Global Emerging Cancer Diagnostics Companies Ranked by Revenue
3.3 Global Emerging Cancer Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Emerging Cancer Diagnostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Emerging Cancer Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Emerging Cancer Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Emerging Cancer Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Emerging Cancer Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Emerging Cancer Diagnostics Market Size Markets, 2021 & 2028
4.1.2 Men
4.1.3 Women
4.2 By Type - Global Emerging Cancer Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Emerging Cancer Diagnostics Revenue, 2017-2022
4.2.2 By Type - Global Emerging Cancer Diagnostics Revenue, 2023-2028
4.2.3 By Type - Global Emerging Cancer Diagnostics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Emerging Cancer Diagnostics Market Size, 2021 & 2028
5.1.2 Blood Cancer
5.1.3 Prostate Cancer
5.1.4 Breast Cancer
5.1.5 Lung Cancer
5.1.6 Others
5.2 By Application - Global Emerging Cancer Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Emerging Cancer Diagnostics Revenue, 2017-2022
5.2.2 By Application - Global Emerging Cancer Diagnostics Revenue, 2023-2028
5.2.3 By Application - Global Emerging Cancer Diagnostics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Emerging Cancer Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global Emerging Cancer Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Emerging Cancer Diagnostics Revenue, 2017-2022
6.2.2 By Region - Global Emerging Cancer Diagnostics Revenue, 2023-2028
6.2.3 By Region - Global Emerging Cancer Diagnostics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Emerging Cancer Diagnostics Revenue, 2017-2028
6.3.2 US Emerging Cancer Diagnostics Market Size, 2017-2028
6.3.3 Canada Emerging Cancer Diagnostics Market Size, 2017-2028
6.3.4 Mexico Emerging Cancer Diagnostics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Emerging Cancer Diagnostics Revenue, 2017-2028
6.4.2 Germany Emerging Cancer Diagnostics Market Size, 2017-2028
6.4.3 France Emerging Cancer Diagnostics Market Size, 2017-2028
6.4.4 U.K. Emerging Cancer Diagnostics Market Size, 2017-2028
6.4.5 Italy Emerging Cancer Diagnostics Market Size, 2017-2028
6.4.6 Russia Emerging Cancer Diagnostics Market Size, 2017-2028
6.4.7 Nordic Countries Emerging Cancer Diagnostics Market Size, 2017-2028
6.4.8 Benelux Emerging Cancer Diagnostics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Emerging Cancer Diagnostics Revenue, 2017-2028
6.5.2 China Emerging Cancer Diagnostics Market Size, 2017-2028
6.5.3 Japan Emerging Cancer Diagnostics Market Size, 2017-2028
6.5.4 South Korea Emerging Cancer Diagnostics Market Size, 2017-2028
6.5.5 Southeast Asia Emerging Cancer Diagnostics Market Size, 2017-2028
6.5.6 India Emerging Cancer Diagnostics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Emerging Cancer Diagnostics Revenue, 2017-2028
6.6.2 Brazil Emerging Cancer Diagnostics Market Size, 2017-2028
6.6.3 Argentina Emerging Cancer Diagnostics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Emerging Cancer Diagnostics Revenue, 2017-2028
6.7.2 Turkey Emerging Cancer Diagnostics Market Size, 2017-2028
6.7.3 Israel Emerging Cancer Diagnostics Market Size, 2017-2028
6.7.4 Saudi Arabia Emerging Cancer Diagnostics Market Size, 2017-2028
6.7.5 UAE Emerging Cancer Diagnostics Market Size, 2017-2028
7 Players Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporate Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Emerging Cancer Diagnostics Major Product Offerings
7.1.4 Abbott Laboratories Emerging Cancer Diagnostics Revenue in Global Market (2017-2022)
7.1.5 Abbott Laboratories Key News
7.2 Danaher
7.2.1 Danaher Corporate Summary
7.2.2 Danaher Business Overview
7.2.3 Danaher Emerging Cancer Diagnostics Major Product Offerings
7.2.4 Danaher Emerging Cancer Diagnostics Revenue in Global Market (2017-2022)
7.2.5 Danaher Key News
7.3 Agilent Technologies
7.3.1 Agilent Technologies Corporate Summary
7.3.2 Agilent Technologies Business Overview
7.3.3 Agilent Technologies Emerging Cancer Diagnostics Major Product Offerings
7.3.4 Agilent Technologies Emerging Cancer Diagnostics Revenue in Global Market (2017-2022)
7.3.5 Agilent Technologies Key News
7.4 AstraZeneca
7.4.1 AstraZeneca Corporate Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Emerging Cancer Diagnostics Major Product Offerings
7.4.4 AstraZeneca Emerging Cancer Diagnostics Revenue in Global Market (2017-2022)
7.4.5 AstraZeneca Key News
7.5 BD
7.5.1 BD Corporate Summary
7.5.2 BD Business Overview
7.5.3 BD Emerging Cancer Diagnostics Major Product Offerings
7.5.4 BD Emerging Cancer Diagnostics Revenue in Global Market (2017-2022)
7.5.5 BD Key News
7.6 Biocept
7.6.1 Biocept Corporate Summary
7.6.2 Biocept Business Overview
7.6.3 Biocept Emerging Cancer Diagnostics Major Product Offerings
7.6.4 Biocept Emerging Cancer Diagnostics Revenue in Global Market (2017-2022)
7.6.5 Biocept Key News
7.7 Illumina
7.7.1 Illumina Corporate Summary
7.7.2 Illumina Business Overview
7.7.3 Illumina Emerging Cancer Diagnostics Major Product Offerings
7.7.4 Illumina Emerging Cancer Diagnostics Revenue in Global Market (2017-2022)
7.7.5 Illumina Key News
7.8 Luminex
7.8.1 Luminex Corporate Summary
7.8.2 Luminex Business Overview
7.8.3 Luminex Emerging Cancer Diagnostics Major Product Offerings
7.8.4 Luminex Emerging Cancer Diagnostics Revenue in Global Market (2017-2022)
7.8.5 Luminex Key News
7.9 NeoGenomics
7.9.1 NeoGenomics Corporate Summary
7.9.2 NeoGenomics Business Overview
7.9.3 NeoGenomics Emerging Cancer Diagnostics Major Product Offerings
7.9.4 NeoGenomics Emerging Cancer Diagnostics Revenue in Global Market (2017-2022)
7.9.5 NeoGenomics Key News
7.10 QIAGEN
7.10.1 QIAGEN Corporate Summary
7.10.2 QIAGEN Business Overview
7.10.3 QIAGEN Emerging Cancer Diagnostics Major Product Offerings
7.10.4 QIAGEN Emerging Cancer Diagnostics Revenue in Global Market (2017-2022)
7.10.5 QIAGEN Key News
7.11 Thermo Fisher Scientific
7.11.1 Thermo Fisher Scientific Corporate Summary
7.11.2 Thermo Fisher Scientific Business Overview
7.11.3 Thermo Fisher Scientific Emerging Cancer Diagnostics Major Product Offerings
7.11.4 Thermo Fisher Scientific Emerging Cancer Diagnostics Revenue in Global Market (2017-2022)
7.11.5 Thermo Fisher Scientific Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Emerging Cancer Diagnostics Market Opportunities & Trends in Global Market
Table 2. Emerging Cancer Diagnostics Market Drivers in Global Market
Table 3. Emerging Cancer Diagnostics Market Restraints in Global Market
Table 4. Key Players of Emerging Cancer Diagnostics in Global Market
Table 5. Top Emerging Cancer Diagnostics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Emerging Cancer Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Emerging Cancer Diagnostics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Emerging Cancer Diagnostics Product Type
Table 9. List of Global Tier 1 Emerging Cancer Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Emerging Cancer Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Emerging Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Emerging Cancer Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Emerging Cancer Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Emerging Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Emerging Cancer Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Emerging Cancer Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Emerging Cancer Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Emerging Cancer Diagnostics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Emerging Cancer Diagnostics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Emerging Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Emerging Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Emerging Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Emerging Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Emerging Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Emerging Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Emerging Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Emerging Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Emerging Cancer Diagnostics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Emerging Cancer Diagnostics Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Emerging Cancer Diagnostics Product Offerings
Table 32. Abbott Laboratories Emerging Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 33. Danaher Corporate Summary
Table 34. Danaher Emerging Cancer Diagnostics Product Offerings
Table 35. Danaher Emerging Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 36. Agilent Technologies Corporate Summary
Table 37. Agilent Technologies Emerging Cancer Diagnostics Product Offerings
Table 38. Agilent Technologies Emerging Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 39. AstraZeneca Corporate Summary
Table 40. AstraZeneca Emerging Cancer Diagnostics Product Offerings
Table 41. AstraZeneca Emerging Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 42. BD Corporate Summary
Table 43. BD Emerging Cancer Diagnostics Product Offerings
Table 44. BD Emerging Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 45. Biocept Corporate Summary
Table 46. Biocept Emerging Cancer Diagnostics Product Offerings
Table 47. Biocept Emerging Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 48. Illumina Corporate Summary
Table 49. Illumina Emerging Cancer Diagnostics Product Offerings
Table 50. Illumina Emerging Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 51. Luminex Corporate Summary
Table 52. Luminex Emerging Cancer Diagnostics Product Offerings
Table 53. Luminex Emerging Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 54. NeoGenomics Corporate Summary
Table 55. NeoGenomics Emerging Cancer Diagnostics Product Offerings
Table 56. NeoGenomics Emerging Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 57. QIAGEN Corporate Summary
Table 58. QIAGEN Emerging Cancer Diagnostics Product Offerings
Table 59. QIAGEN Emerging Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
Table 60. Thermo Fisher Scientific Corporate Summary
Table 61. Thermo Fisher Scientific Emerging Cancer Diagnostics Product Offerings
Table 62. Thermo Fisher Scientific Emerging Cancer Diagnostics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Emerging Cancer Diagnostics Segment by Type in 2021
Figure 2. Emerging Cancer Diagnostics Segment by Application in 2021
Figure 3. Global Emerging Cancer Diagnostics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Emerging Cancer Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Emerging Cancer Diagnostics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Emerging Cancer Diagnostics Revenue in 2021
Figure 8. By Type - Global Emerging Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Emerging Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Emerging Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Emerging Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 12. US Emerging Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Emerging Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Emerging Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Emerging Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 16. Germany Emerging Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 17. France Emerging Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Emerging Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Emerging Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Emerging Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Emerging Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Emerging Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Emerging Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 24. China Emerging Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Emerging Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Emerging Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Emerging Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 28. India Emerging Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Emerging Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 30. Brazil Emerging Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Emerging Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Emerging Cancer Diagnostics Revenue Market Share, 2017-2028
Figure 33. Turkey Emerging Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Emerging Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Emerging Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Emerging Cancer Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Laboratories Emerging Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Danaher Emerging Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Agilent Technologies Emerging Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. AstraZeneca Emerging Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. BD Emerging Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Biocept Emerging Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Illumina Emerging Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Luminex Emerging Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. NeoGenomics Emerging Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. QIAGEN Emerging Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Thermo Fisher Scientific Emerging Cancer Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
